Fribourg, Switzerland

Bernard Lucien Roy

USPTO Granted Patents = 11 

 

Average Co-Inventor Count = 4.8

ph-index = 6

Forward Citations = 65(Granted Patents)


Company Filing History:


Years Active: 2010-2017

Loading Chart...
Loading Chart...
11 patents (USPTO):

Title: The Innovations of Bernard Lucien Roy

Introduction

Bernard Lucien Roy is a notable inventor based in Fribourg, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target nicotinic acetylcholine receptors. With a total of 11 patents to his name, Roy's work has the potential to impact the treatment of various psychotic and neurodegenerative disorders.

Latest Patents

One of Roy's latest patents is focused on substituted quinuclidines as alpha 7-nicotinic acetylcholine receptor activity modulators. This invention relates to 1-aza-bicycloalkyl derivatives of a specific formula, which are designed for use as pharmaceuticals in the prevention and treatment of psychotic and neurodegenerative disorders. The claimed compounds act as ligands for nicotinic acetylcholine receptors (NACHR).

Another significant patent involves 1-aza-bicyclo[3.3.1]nonanes. This invention also pertains to 1-aza-bicycloalkyl derivatives of a defined formula, detailing processes for their production and their use in pharmaceutical compositions. The compounds are presented in free base or acid addition salt form, showcasing their versatility in medicinal applications.

Career Highlights

Bernard Lucien Roy is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on innovative pharmaceutical research and development. His contributions have been instrumental in advancing the understanding and treatment of complex neurological conditions.

Collaborations

Throughout his career, Roy has collaborated with several talented individuals, including Dominik Feuerbach and Mathias Frederiksen. These collaborations have fostered a productive environment for innovation and have led to the successful development of new pharmaceutical compounds.

Conclusion

Bernard Lucien Roy's work exemplifies the impact of innovation in the pharmaceutical industry. His patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes. His contributions continue to pave the way for future discoveries in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…